Skip to content

LSD: all studies

Page 231 of 282: studies 2,301 to 2,310 of 2,815, newest first. Back to the LSD overview

Research

TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?

Neuropharmacology November 2018 Giuseppe Di Giovanni, Philippe De Deurwaerdère

The development of 5-HT2A receptor agonists has been considerably marginalized since the demonstration that the tryptaminergic drugs, LSD and psilocybin, or the phenylakylamine drugs, mescaline and DOI, exert their hallucinogenic properties via the stimulation of 5-HT2A receptors. Nonetheless, the ability of drugs to stimulate 5-HT2A receptors is not necessarily associated with psychedelic...

Why MDMA therapy for alcohol use disorder? And why now?

Neuropharmacology November 1, 2018 Ben Sessa 61 citations

Alcohol use disorder represents a serious clinical, social and personal burden on its sufferers and a significant financial strain on society. Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedicated treatment programs. The earliest historical roots of psychedelic drug-assisted psychotherapy in the 1950s were...

Confronting Death: An Experiential Imagery Exercise

Routledge eBooks October 26, 2018 Anees Ahmad Sheikh

This exercise, the group first is engages in a general discusses of death and dying and the life–giving qualities that ensue from an encounter with death. The simple procedure almost always elicits profound reactions, particularly from adults in the late thirties and older. Imagine that as body is buries or cremated, essence merges with the source of the universe, with the universal energy,...

Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.

Progress in Brain Research October 25, 2018 Selen Atasoy, Jakub Vohryzek, Gustavo Deco et al. 67 citations

The search for the universal laws of human brain function is still on-going but progress is being made. Here we describe the novel concepts of connectome harmonics and connectome-harmonic decomposition, which can be used to characterize the brain activity associated with any mental state. We use this new frequency-specific language to describe the brain activity elicited by psilocybin and LSD...

DOI: 10.1016/bs.pbr.2018.08.009 (opens in new tab) Psychedelics: psychedelic compounds Substances Various psychedelics Brain wave rhythms +9

The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug

Psychopharmacology October 4, 2018 Baland Jalal 42 citations

Sleep paralysis is a state of involuntary immobility occurring at sleep onset or offset, often accompanied by uncanny “ghost-like” hallucinations and extreme fear reactions. I provide here a neuropharmacological account for these hallucinatory experiences by evoking the role of the serotonin 2A receptor (5-HT2AR). Research has shown that 5-HT2AR activation can induce visual hallucinations,...

Ketamine and Electroconvulsive Therapy for Depression.

Journal of neurosurgical anesthesiology October 1, 2018 C. Andrade

K anesthesia was introduced about half a century ago. In recent decades, this drug, in subanesthetic doses, has also demonstrated efficacy for off-label indications including treating acute and chronic pain, treating agitation, treating depression, and inducing sedation. Thus, there are studies of subanesthetic dosing with ketamine for treating pain in emergency medicine settings, treating...

1/f electrophysiological spectra in resting and drug-induced states can be explained by the dynamics of multiple oscillatory relaxation processes.

Neuroimage October 1, 2018 Suresh Muthukumaraswamy, David Tj Liley

Neurophysiological recordings are dominated by arhythmical activity whose spectra can be characterised by power-law functions, and on this basis are often referred to as reflecting scale-free brain dynamics (1/fβ). Relatively little is known regarding the neural generators and temporal dynamics of this arhythmical behaviour compared to rhythmical behaviour. Here we used Irregularly Resampled...

DOI: 10.1016/j.neuroimage.2018.06.068 (opens in new tab) Full text (opens in new tab) Electrocorticography Electroencephalography Magnetoencephalography Power spectrum +1

Seizures, Systemic Inflammatory Response, and Rhabdomyolysis Associated With Laboratory-Confirmed 2C-I and 25-I Exposure.

Pediatric Emergency Care October 1, 2018 Stephen L Thornton, Sarah Hoehn, Roy R Gerona 6 citations

The 2C drugs are hallucinogenic phenethylamines. They and their n-benzyloxymethyl analogs have become popular as "legal highs," and significant toxicity has been attributed to their use. We report on a case of seizures, systemic inflammatory response, and rhabdomyolysis associated with laboratory-confirmed 4-iodo-2,5-dimethoxyphenethylamine and 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)...

DOI: 10.1097/PEC.0000000000001117 (opens in new tab) Full text (opens in new tab) Designer drugs Drug toxicity Toxicology testing Neurological emergencies

Trends in DMT and other tryptamine use among young adults in the United States

American Journal on Addictions September 27, 2018 Joseph J Palamar, Austin Le 35 citations

Background and Objectives The popularity of tryptamines such as N,N ‐dimethyltryptamine (DMT) appears to be increasing in the United States (US), but epidemiologic literature on prevalence of use is scant. This paper aims to determine trends in prevalence and correlates of past‐year tryptamine use among a nationally representative sample of young adults in the US. Methods Participants in the...